Abeona Therapeutics Inc. (ABEO) Financial Statements (2023 and Earlier)

Company Profile

Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
NEW YORK, NY 10019
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:50,90095,000129,25885,000137,75069,14240,138
Cash and cash equivalents32,93812,596129,25818,750137,75069,14240,138
Short-term investments12,08682,438 66,218   
Other undisclosed cash, cash equivalents, and short-term investments5,876(34) 32   
Receivables3,000  81107124115
Other undisclosed current assets1,5012,7423,1323,7702,735155315
Total current assets:55,40197,742132,39088,851140,59269,42140,568
Noncurrent Assets
Operating lease, right-of-use asset9,4037,0328,047
Property, plant and equipment12,33911,32213,1579,4431,374721350
Intangible assets, net (including goodwill)1,38433,96668,64475,50836,44340,85039,075
Goodwill 32,46632,46632,46632,46632,46632,466
Intangible assets, net (excluding goodwill)1,3841,50036,17843,0423,9778,3846,609
Other undisclosed noncurrent assets1,0591,1361,1445973576662
Total noncurrent assets:24,18553,45690,99285,54838,17441,63739,487
TOTAL ASSETS:79,586151,198223,382174,399178,766111,05880,055
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,9108,1059,30610,0582,3933,694875
Accounts payable4,3254,6953,7636,1222,3933,694875
Accrued liabilities5,5853,4105,5433,936   
Deferred revenue296296296
Debt 3301,699    
Due to related parties4,59931,51527,400    
Deferred revenue and credits3,214602602
Other undisclosed current liabilities1,8181,713 10,296 4,000 
Total current liabilities:16,62341,95938,70120,3545,6078,2961,477
Noncurrent Liabilities
Long-term debt and lease obligation7,5606,6886,251    
Long-term debt, excluding current maturities 1,428     
Operating lease, liability7,5605,2606,251
Liabilities, other than long-term debt4,028   3,0613,6646,857
Deferred revenue and credits3,0613,6644,266
Due to related parties3,828      
Other liabilities200      
Business combination, contingent consideration, liability      2,591
Other undisclosed noncurrent liabilities (5,260) 20,000  4,000
Total noncurrent liabilities:11,5886,6886,25120,0003,0613,66410,857
Total liabilities:28,21148,64744,95240,3548,66811,96012,334
Stockholders' equity
Stockholders' equity attributable to parent51,375102,551178,430134,045170,09899,09867,721
Common stock1,472961836479469403328
Additional paid in capital705,570672,304664,064543,754529,421431,168377,993
Accumulated other comprehensive loss(27)(10)     
Accumulated deficit(655,640)(570,704)(486,470)(410,188)(359,792)(332,473)(310,600)
Total stockholders' equity:51,375102,551178,430134,045170,09899,09867,721
TOTAL LIABILITIES AND EQUITY:79,586151,198223,382174,399178,766111,05880,055

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues3,00010,000 2,9988378891,040
Revenue, net8378891,040
Cost of revenue   (1,186)(661)(677)(538)
Gross profit:3,00010,000 1,812176212502
Operating expenses(92,836)(91,420)(77,090)(59,978)(28,012)(24,093)(19,048)
Operating loss:(89,836)(81,420)(77,090)(58,166)(27,836)(23,881)(18,546)
Nonoperating income   1,5065172,0084,020
Investment income, nonoperating   1,5065252,0144,026
Interest and debt expense(3,670)(4,115)(400)   (6)
Net loss:(93,506)(85,535)(77,490)(56,660)(27,319)(21,873)(14,532)
Other undisclosed net income (loss) attributable to parent8,5701,3011,208(11)  6
Net loss available to common stockholders, diluted:(84,936)(84,234)(76,282)(56,671)(27,319)(21,873)(14,526)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(93,506)(85,535)(77,490)(56,660)(27,319)(21,873)(14,532)
Other comprehensive loss(17)      
Comprehensive loss:(93,523)(85,535)(77,490)(56,660)(27,319)(21,873)(14,532)
Other undisclosed comprehensive income, net of tax, attributable to parent8,5701,291     
Comprehensive loss, net of tax, attributable to parent:(84,953)(84,244)(77,490)(56,660)(27,319)(21,873)(14,532)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: